CDC in Namibia
One of the informal settlements in Windhoek, capital of Namibia. Photo by Rachel Coomer/CDC.
The Centers for Disease Control and Prevention (CDC) established an office in Namibia in 2002, with satellite offices to implement focused HIV programs in high-burden regions. CDC collaborates with the Namibia Ministry of Health and Social Services (MOHSS) to build the capacity of Namibia’s healthcare workforce and systems to prevent, detect, and respond to public health threats, with a primary focus on ending the HIV/AIDS epidemic and maintaining the care and treatment of those living with HIV.
CDC Impact in Namibia
Global Health Security
Countries that have strong and resilient public health systems can quickly prevent, detect, and respond to infectious disease threats before they become epidemics. CDC strengthens the MOHSS health system through workforce capacity building including supporting the Field Epidemiology and Laboratory Training Program (FELTP). Graduates from the FELTP program play a significant role in disease outbreak investigations. CDC Namibia has also directly supported a range of outbreak investigations including Crimean-Congo hemorrhagic fever, rabies among livestock with human exposures, anthrax in animals, cholera, listeriosis, Hepatitis E, and H1N1 influenza.
Namibia conducted a Threat and Hazard Identification and Risk Assessment evaluation in 2017, joined the Global Health Security Agenda in 2019 and in December 2020 launched a National Action Plan for Health Security
Global health security investments and decades of global cooperation have built a strong foundation in Namibia to respond to the coronavirus pandemic. CDC has supported past responses to outbreaks, and initiated and evaluated programs to control HIV, TB, malaria, eradicate polio, and prepare for influenza and other pandemic diseases. CDC’s COVID-19 support in Namibia includes:
- Response and logistics coordination
- Enhancing diagnostic capacity
- Surveillance and case management
- Quarantine management
- Case investigation
- Infection prevention and control
- Risk communication
- Vaccine activities
CDC Namibia has hired over 121 personnel into MOHSS to support the COVID-19 response
HIV is a leading cause of death and a health threat to millions worldwide. As a key implementer of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC works with Namibia to develop and implement a sustainable and integrated, high-impact package of HIV prevention, care, and treatment programs.
CDC’s work with MOHSS includes a focus on building workforce capacity to ensure there are sufficient skilled public health professionals. Additionally, CDC works with MOHSS to strengthen laboratory systems in order to scale up and improve HIV and TB diagnostics as well as timely viral load testing.
CDC also provides technical assistance to strengthen surveillance and health information systems to collect and analyze data for improved program decision-making. CDC works with MOHSS to scale up national antiretroviral treatment programs and improve HIV prevention efforts, including:
- HIV testing services
- Prevention of mother-to-child transmission
- Antiretroviral therapy
- Pre-exposure prophylaxis
- Post-exposure prophylaxis
CDC provides widespread technical assistance to MOHSS and partners to implement evidence-based care and treatment activities. Namibia is near to HIV epidemic control and is now focusing on ensuring all people, particularly underserved groups such as children and adolescents, are receiving the targeted care packages they need. CDC focuses on ensuring that prevention, care and treatment options are optimally designed and client-centered. This ranges from supporting Namibia to offer efficient and effective treatment options for stable patients who do not need intensive support from clinics, to ensuring that people living with HIV who have not yet had their treatment options optimized receive the care they need.
CDC also supports the broader healthcare needs of HIV-positive patients. CDC ensures that life-saving cervical cancer screening and treatment is available to HIV-positive women. They are five times more likely to develop cervical cancer than a woman who is HIV-negative.
CDC places a strong focus on supporting research capacity. CDC supported the Namibia population-based HIV impact assessment (NAMPHIA 2017). Results showed that 77% of all HIV-positive adults achieved viral load suppression, which surpasses the UNAIDS target of 73% by 2020. CDC provided technical assistance to implement the second integrated bio-behavioral surveillance survey in 2019, a data source that can improve program decision-making. Also in 2019, CDC supported Namibia to conduct its first Violence Against Children Survey.
CDC supports new UNAIDS 95-95-95 targets for HIV treatment: 95% of people living with HIV know their status; 95% of people who know their status are on treatment; and 95% of people on treatment achieve viral load suppression
TB is found in every country in the world and kills more people than any other infectious disease. CDC collaborates with MOHSS to protect healthcare workers and reduce the spread of TB through trainings and capacity building, particularly around the correct use of particulate-filtering respirators. CDC also supports comprehensive TB and HIV activities in Namibia, including:
- Improving and integrating TB and HIV services for co-infected individuals
- Providing TB preventative therapy for all eligible HIV-positive individuals
- Supporting TB infection control efforts in healthcare facilities
To reduce the spread of COVID-19 among HIV-positive patients who need TB preventive therapy, implementing partners, with support from CDC, provide a full course of TB preventative medicine to patients. This reduces office visits during the pandemic
Laboratory Capacity Building
Strong laboratories allow for better detection of emerging diseases, provide critical health information, and create safer handling and transportation of laboratory samples. CDC supports MOHSS to strengthen the quality of the national laboratory system in Namibia. The Namibia Institute of Pathology (NIP) receives CDC technical support to provide accurate HIV diagnostics and timely viral load testing. As Namibia continues to work toward reaching the target of 95% of all HIV individuals on antiretroviral treatment maintaining viral load suppression, a strong lab system and network is critical. CDC works with NIP to ensure the quality of all HIV and tuberculosis testing nationally. Following the COVID-19 pandemic, CDC has strongly supported the national COVID-19 testing system to design workflow, conduct training, and ensure biosafety in the laboratory at all times.
Namibia has gone from having a backlog of over 10 days to receive COVID-19 test results, down to 24-72 hours from receipt of samples in the testing laboratory
- Making Schools in Namibia Safer During the COVID-19 Pandemic
- Collecting four months of medicine: Stepping up HIV patient care during a global pandemic (cdc.gov)
- Treating TB During the Time of COVID-19 | CDC
- When borders are shut: Providing ART medicine to all patients during the COVID-19 pandemic | CDC
- 10 U.S. Assignees
- 36 Locally Employed
- Population: > 2,540,000
- Per capita income: > $9,200
- Life expectancy: F 67 / M 61 years
- Infant mortality rate: 30/1,000 live births
Sources: World Bank 2020, Population Reference Bureau